Janus Henderson Group
RLAY icon

Janus Henderson Group’s Relay Therapeutics RLAY Stock Holding History

Janus Henderson Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$652K Buy
65,573
+28,700
+78% +$257K ﹤0.01% 1886
2025
Q4 		$312K Hold
36,873
– – ﹤0.01% 2193
2025
Q3 		$193K Hold
36,873
– – ﹤0.01% 2350
2025
Q2 		$128K Hold
36,873
– – ﹤0.01% 2379
2025
Q1 		$100K Hold
36,873
– – ﹤0.01% 2459
2024
Q4 		$152K Hold
36,873
– – ﹤0.01% 2475
2024
Q3 		$261K Hold
36,873
– – ﹤0.01% 2334
2024
Q2 		$241K Sell
36,873
-469
-1% -$3.21K ﹤0.01% 2316
2024
Q1 		$309K Buy
37,342
+29
+0.1% +$283 ﹤0.01% 2222
2023
Q4 		$410K Sell
37,313
-58
-0.2% -$489 ﹤0.01% 2085
2023
Q3 		$314K Sell
37,371
-3
-0% -$32 ﹤0.01% 2161
2023
Q2 		$469K Sell
37,374
-46
-0.1% -$572 ﹤0.01% 2013
2023
Q1 		$617K Buy
37,420
+19,090
+104% +$342K ﹤0.01% 1897
2022
Q4 		$274K Sell
18,330
-5,930
-24% -$114K ﹤0.01% 2016
2022
Q3 		$542K Buy
24,260
+7,478
+45% +$164K ﹤0.01% 1913
2022
Q2 		$281K Buy
+16,782
New +$360K ﹤0.01% 2118
2021
Q4 		– Sell
-17,004
Closed -$534K – 2580
2021
Q3 		$534K Sell
17,004
-7,236
-30% -$244K ﹤0.01% 1580
2021
Q2 		$884K Sell
24,240
-68,690
-74% -$2.26M ﹤0.01% 1346
2021
Q1 		$3.21M Sell
92,930
-5,162
-5% -$224K ﹤0.01% 1097
2020
Q4 		$4.08M Sell
98,092
-388,519
-80% -$17.6M ﹤0.01% 998
2020
Q3 		$20.7M Buy
+486,611
New +$18.6M 0.01% 699

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group's RLAY Position: Q1 2026 in Review

Janus Henderson Group increased its Relay Therapeutics (RLAY) stake by 78% in Q1 2026, buying an estimated $257K and bringing the position to 65,573 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Janus Henderson Group first reported a position in RLAY in Q3 2020 and has held it in 21 quarters since. The position peaked at $20.7M in Q3 2020. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Janus Henderson Group held 65,573 shares of Relay Therapeutics worth $652K as of Q1 2026.
  • Janus Henderson Group bought 28,700 Relay Therapeutics shares in Q1 2026, an estimated $257K.
  • Relay Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1886 holding.
  • Janus Henderson Group first reported a position in Relay Therapeutics in Q3 2020 and has held it in 21 quarters since.
  • Janus Henderson Group's Relay Therapeutics position peaked at $20.7M in Q3 2020.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.